PLEASE NOTE : This is a development system.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
For Surrey PAD, please go to https://surreyccg.res-systems.net/PAD.
You are here : Home > PAD Profile : Baclofen - Spasticity and muscle spasm
PAD Profile : Baclofen - Spasticity and muscle spasm
Keywords :
skeletal muscle relaxants, muscle spasm
Brand Names Include :
Lioresal, Lyflex
Traffic Light Status
Status 1 of 2.
Status :
Green
Formulations :
- Oral solution
- Tablets
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Status 2 of 2.
Status :
Red
Important
Formulations :
- Intrathecal injection
Important Information :
Severe chronic spasticity where oral drugs are intolerable or ineffective. Alternative to ablative neurosurgical procedures (specialist use only)
Trust Alignment :
Primary Care
ASPH
RSFT
SASH
SABP
Comments :
No comments returned.
Documents :
Guidelines
No guidelines returned.
Other Drugs
Other Indications
No indications returned.
Additional Documents
No additional documents returned.
Committee Recommendations
Date
Committee Name
Narrative
03 May 2017
Surrey & North West Sussex Area Prescribing Committee (formerly Prescribing Clinical Network)
Baclofen has been considered by the PCN and has been assigned a GREEN traffic light status, within its LICENSED indication(s).
NOTE - the branded product (Lioresal) was considered BLACK at the PCN in May 2017.
Associated BNF Codes
10. Musculoskeletal and Joint Diseases
10.02.02. Skeletal muscle relaxants